Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Borggraefe

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Clinical Genetics|February 23, 2021
De novo variants in neurodevelopmental disorders-experiences from a tertiary care centerTheresa Brunet, Robert Jech, Melanie Brugger, et al.
Brain : a Journal of Neurology|August 15, 2018
SYT1-associated neurodevelopmental disorder: a case seriesKate Baker, Sarah L Gordon, Holly Melland, et al.
Epilepsia|March 1, 2025
Seizure outcomes following epilepsy surgery in pediatric and young adult patients with high-grade brain tumors: Results from a European surveyRobert Lersch, Till Hartlieb, Tom Pieper, et al.
Neuropediatrics|August 30, 2024
Characterization of the Epileptogenic Phenotype and Response to Antiseizure Medications in Lissencephaly PatientsChristiane R Proepper, Sofia M Schuetz, Lisa-Maria Schwarz, et al.
Epilepsia Open|January 24, 2023
Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter studyFabienne Kühne, Lena-Luise Becker, Thomas Bast, et al.
Orphanet Journal of Rare Diseases|May 23, 2026
Gene-specific long-term course, neurodevelopmental outcome and quality of life in patients with LIS1/PAFAH1B1-, DCX-, DYNC1H1-, TUBA1A- and TUBG1-related lissencephalyChristiane R Proepper, Lisa-Maria Schwarz, Sofia M Schuetz, et al.
JAMA Neurology|August 15, 2017
Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and PhenotypesCarolien G F de Kovel, Steffen Syrbe, Eva H Brilstra, et al.
Epilepsia|April 2, 2026
Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain-expressed sodium channelopathiesSopio Gverdtsiteli, Sebastian Ortiz, Tobias Brünger, et al.
Journal of Medical Genetics|March 19, 2016
Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsyCyril Mignot, Celina von Stülpnagel, Caroline Nava, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 17, 2009
The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsyFlorian Heinen, Kaat Desloovere, A Sebastian Schroeder, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Clinical Genetics|February 23, 2021
De novo variants in neurodevelopmental disorders-experiences from a tertiary care centerTheresa Brunet, Robert Jech, Melanie Brugger, et al.
Brain : a Journal of Neurology|August 15, 2018
SYT1-associated neurodevelopmental disorder: a case seriesKate Baker, Sarah L Gordon, Holly Melland, et al.
Epilepsia|March 1, 2025
Seizure outcomes following epilepsy surgery in pediatric and young adult patients with high-grade brain tumors: Results from a European surveyRobert Lersch, Till Hartlieb, Tom Pieper, et al.
Neuropediatrics|August 30, 2024
Characterization of the Epileptogenic Phenotype and Response to Antiseizure Medications in Lissencephaly PatientsChristiane R Proepper, Sofia M Schuetz, Lisa-Maria Schwarz, et al.
Epilepsia Open|January 24, 2023
Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter studyFabienne Kühne, Lena-Luise Becker, Thomas Bast, et al.
Orphanet Journal of Rare Diseases|May 23, 2026
Gene-specific long-term course, neurodevelopmental outcome and quality of life in patients with LIS1/PAFAH1B1-, DCX-, DYNC1H1-, TUBA1A- and TUBG1-related lissencephalyChristiane R Proepper, Lisa-Maria Schwarz, Sofia M Schuetz, et al.
JAMA Neurology|August 15, 2017
Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and PhenotypesCarolien G F de Kovel, Steffen Syrbe, Eva H Brilstra, et al.
Epilepsia|April 2, 2026
Neonatal developmental and epileptic encephalopathy with movement disorder and arthrogryposis: A shared phenotype across brain-expressed sodium channelopathiesSopio Gverdtsiteli, Sebastian Ortiz, Tobias Brünger, et al.
Journal of Medical Genetics|March 19, 2016
Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsyCyril Mignot, Celina von Stülpnagel, Caroline Nava, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 17, 2009
The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsyFlorian Heinen, Kaat Desloovere, A Sebastian Schroeder, et al.
Pageof 9